MORNEAU MICHAEL 4
4 · Viking Therapeutics, Inc. · Filed Aug 2, 2019
Insider Transaction Report
Form 4
MORNEAU MICHAEL
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-07-31+7,500→ 7,500 totalExercise: $7.69From: 2020-07-31Exp: 2029-07-31→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]1/3 of the shares subject to the option will vest on each anniversary of the grant date.